Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2013

01.12.2013 | Original Article

Polymorphisms in Mn-SOD and EC-SOD gene and risk of nephropathy in Western Indian Type 2 diabetic patients

verfasst von: Hitesh Vashrambhai Patel, Kiran Kalia

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Single-nucleotide polymorphisms in genes related to oxidative stress are a risk factor for the development of diabetes and its complications. The allele and genotype frequencies of missense polymorphism Ala-9Val and Val16Ala in Mn-SOD and Arg213Gly in EC-SOD genes were studied in (a) patients with Type 2 diabetes mellitus (T2DM) without any complication (T2DM), (b) diabetic nephropathy (DN), (c) non-diabetic nephropathy (NDN) and (d) control healthy subjects from Western region of India. The PCR products were digested with BshTI, BsaWI and Eco52I restriction enzymes to detect Ala-9Val, Val16Ala and Arg213Gly polymorphisms respectively. The frequency of Val allele of Ala-9Val (P = 0.568 and P = 0.571) and Ala allele of Val16Ala (P = 0.993 and P = 0.152) polymorphisms of Mn-SOD gene did not show a significant difference in patient with T2DM and NDN compared to control subjects respectively. Frequency of Val allele of Ala-9Val (42.8 % vs. 61.5 %, P < 0.001) and Ala allele of Val16Ala (39.0 % vs. 53.5 %, P = 0.005) polymorphisms of Mn-SOD gene was significantly higher in patients with DN than that of patient with T2DM. For Arg213Gly polymorphism of EC-SOD gene, the Gly allele frequency in T2DM and NDN group did not significantly (P = 0.993 and P = 0.152 respectively) differ from control subjects as well as non-significantly higher in DN compared to T2DM. These results suggests that Ala-9Val and Val16Ala polymorphism in Mn-SOD is not involved in development of diabetes but may play a crucial role in determining genetic susceptibility to diabetic nephropathy in Western Indian Type 2 diabetic patients. Our data found a lack of association of EC-SOD (Arg213Gly) polymorphism with development of diabetes and diabetic nephropathy.
Literatur
1.
Zurück zum Zitat King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.PubMedCrossRef King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.PubMedCrossRef
2.
Zurück zum Zitat Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med. 2003;4:S3–10.PubMed Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med. 2003;4:S3–10.PubMed
3.
Zurück zum Zitat Dalla VM, Saller A, Bortoloso E, Mauer M, Fioretto P. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab. 2000;26:8–14. Dalla VM, Saller A, Bortoloso E, Mauer M, Fioretto P. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab. 2000;26:8–14.
4.
Zurück zum Zitat Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–76.PubMedCrossRef Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–76.PubMedCrossRef
5.
Zurück zum Zitat American Diabetes Association. Diabetic nephropathy. Diabetes Care. 2002;25(Supplement)1:S85–S89. American Diabetes Association. Diabetic nephropathy. Diabetes Care. 2002;25(Supplement)1:S85–S89.
6.
Zurück zum Zitat Dave GS, Kalia K. Hyperglycemia, reactive oxygen species and pathophysiology of diabetic nephropathy. J Cell Tissue Res. 2008;8:1367–77. Dave GS, Kalia K. Hyperglycemia, reactive oxygen species and pathophysiology of diabetic nephropathy. J Cell Tissue Res. 2008;8:1367–77.
7.
Zurück zum Zitat Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167–78.PubMedCrossRef Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167–78.PubMedCrossRef
8.
Zurück zum Zitat Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet. 2008;9:30.PubMedCentralPubMedCrossRef Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet. 2008;9:30.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599–622.PubMedCrossRef Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599–622.PubMedCrossRef
10.
Zurück zum Zitat Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161–4.PubMedCrossRef Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161–4.PubMedCrossRef
11.
Zurück zum Zitat Hansen L, Pedersen O. Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes Metab. 2005;7:122–35.PubMedCrossRef Hansen L, Pedersen O. Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes Metab. 2005;7:122–35.PubMedCrossRef
12.
Zurück zum Zitat Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC. Genetic determinants of diabetic nephropathy. Clin Sci. 1999;96:221–30.PubMedCrossRef Chowdhury TA, Dyer PH, Kumar S, Barnett AH, Bain SC. Genetic determinants of diabetic nephropathy. Clin Sci. 1999;96:221–30.PubMedCrossRef
13.
Zurück zum Zitat Maritim AC, Sanders RA, Watkins JB. 3rd diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.PubMedCrossRef Maritim AC, Sanders RA, Watkins JB. 3rd diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.PubMedCrossRef
14.
Zurück zum Zitat Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparisons of the CuZn-SOD (SOD1), Mn-SOD (SOD2), AND EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.PubMedCrossRef Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparisons of the CuZn-SOD (SOD1), Mn-SOD (SOD2), AND EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.PubMedCrossRef
15.
16.
Zurück zum Zitat Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson’s disease. Biochem Biophys Res Commun. 1996;226:561–5.PubMedCrossRef Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson’s disease. Biochem Biophys Res Commun. 1996;226:561–5.PubMedCrossRef
17.
Zurück zum Zitat Chistyakov DA, Savost’anov KV, Zotova EV, Nosikov VV. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet. 2001;2:4.PubMedCentralPubMedCrossRef Chistyakov DA, Savost’anov KV, Zotova EV, Nosikov VV. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet. 2001;2:4.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Patel HV, Kalia K, Mannari J. Angiotensin converting enzyme (ACE) gene polymorphism increases the susceptibility of diabetic nephropathy in Western Indian Type 2 diabetic patients. Int J Diab Dev Ctries. 2011;31:223–9.CrossRef Patel HV, Kalia K, Mannari J. Angiotensin converting enzyme (ACE) gene polymorphism increases the susceptibility of diabetic nephropathy in Western Indian Type 2 diabetic patients. Int J Diab Dev Ctries. 2011;31:223–9.CrossRef
19.
Zurück zum Zitat Mathew CGP. The isolation of high molecular weight eukaryotic DNA. In Walker J, (editor). Methods of mol biol. Vol. 2. Humana Press; 1984. pp. 31–34. Mathew CGP. The isolation of high molecular weight eukaryotic DNA. In Walker J, (editor). Methods of mol biol. Vol. 2. Humana Press; 1984. pp. 31–34.
20.
Zurück zum Zitat Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic Res. 2007;41:770–8.PubMedCrossRef Elsakka NE, Webster NR, Galley HF. Polymorphism in the manganese superoxide dismutase gene. Free Radic Res. 2007;41:770–8.PubMedCrossRef
21.
Zurück zum Zitat Tiwari AK, Prasad P, Thelma BK, Prasanna Kumar KM, Ammini AC, Gupta A, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with type 2 diabetes. J Diabetes Complicat. 2009;23:102–11.PubMedCrossRef Tiwari AK, Prasad P, Thelma BK, Prasanna Kumar KM, Ammini AC, Gupta A, et al. Oxidative stress pathway genes and chronic renal insufficiency in Asian Indians with type 2 diabetes. J Diabetes Complicat. 2009;23:102–11.PubMedCrossRef
22.
Zurück zum Zitat Liu L, Zheng T, Wang N, Wang F, Li M, Jiang J, et al. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem. 2009;322:87–91.PubMedCrossRef Liu L, Zheng T, Wang N, Wang F, Li M, Jiang J, et al. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol Cell Biochem. 2009;322:87–91.PubMedCrossRef
23.
Zurück zum Zitat Lee SJ, Choi MG, Kim DS, Kim TW. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 2006;55:1–7.PubMedCrossRef Lee SJ, Choi MG, Kim DS, Kim TW. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 2006;55:1–7.PubMedCrossRef
24.
Zurück zum Zitat Zotova EV, Chistyakov DA, Savost’yanov EV, Bursa TR, Galeev IV, Strokov IA, et al. Association of the SOD2 Ala(−9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1. Mol Biol. 2003;37:345–8.CrossRef Zotova EV, Chistyakov DA, Savost’yanov EV, Bursa TR, Galeev IV, Strokov IA, et al. Association of the SOD2 Ala(−9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1. Mol Biol. 2003;37:345–8.CrossRef
25.
Zurück zum Zitat Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003;48:138–41.PubMed Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003;48:138–41.PubMed
26.
Zurück zum Zitat Van Landeghem GF, Tabatabaie P, Kucinskas V, Saha N, Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered. 1999;49:190–3.PubMedCrossRef Van Landeghem GF, Tabatabaie P, Kucinskas V, Saha N, Beckman G. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered. 1999;49:190–3.PubMedCrossRef
27.
Zurück zum Zitat Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, et al. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology. 2000;23:170–7.PubMedCrossRef Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, et al. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology. 2000;23:170–7.PubMedCrossRef
28.
Zurück zum Zitat Adachi T, Ohta H, Hirano K, Hayashi K, Marklund SL. Non enzymatic glycation of human extracellular superoxide dismutase. Biochem J. 1991;279:263–7.PubMed Adachi T, Ohta H, Hirano K, Hayashi K, Marklund SL. Non enzymatic glycation of human extracellular superoxide dismutase. Biochem J. 1991;279:263–7.PubMed
29.
Zurück zum Zitat Tamai MT, Furuta H, Kawashima H, Doi A, Hamanishi T, Shimomura H, et al. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract. 2006;71:140–5.PubMedCrossRef Tamai MT, Furuta H, Kawashima H, Doi A, Hamanishi T, Shimomura H, et al. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract. 2006;71:140–5.PubMedCrossRef
30.
Zurück zum Zitat Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol. 2009;20:1303–13.PubMedCrossRef Fujita H, Fujishima H, Chida S, Takahashi K, Qi Z, Kanetsuna Y, et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol. 2009;20:1303–13.PubMedCrossRef
Metadaten
Titel
Polymorphisms in Mn-SOD and EC-SOD gene and risk of nephropathy in Western Indian Type 2 diabetic patients
verfasst von
Hitesh Vashrambhai Patel
Kiran Kalia
Publikationsdatum
01.12.2013
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2013
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-013-0156-9

Weitere Artikel der Ausgabe 4/2013

International Journal of Diabetes in Developing Countries 4/2013 Zur Ausgabe